Firefinch Software’s Post

🩺 💰 NHS & NICE - National Institute for Health and Care Excellence propose new route to give #MedTech developers speedier access to NHS funding With the aim of fast-tracking clinically and cost-effective products for use by the healthcare system, #NHS patients in England will benefit from access to the most innovative and cutting-edge medical technologies, under new plans to ensure NICE recommended products can be introduced on a large-scale, more quickly. The proposals in the consultation document have been developed by NHS England and NICE with input from the Department of Health and Social Care and other partners, including the Office for Life Sciences and the Medicines and Healthcare products Regulatory Agency. Along with improving outcomes for patients, the proposals in the consultation will provide greater certainty for MedTech developers – with a commitment to automatic funding to support routine commissioning for those technologies that meet a required criteria. Read in full: https://lnkd.in/e2QfsVAJ

Council for International Organizations of Medical Sciences (CIOMS) Newsletter #June 2024 CIOMS's recent newsletter showcases significant progress, including a comprehensive report on real-world data and evidence in regulatory decision-making—an indispensable tool for regulators, healthcare payers, and industry professionals. They also unveiled a draft report on severe cutaneous adverse reactions (SCAR) to improve recognition and treatment. Additionally, CIOMS is leading initiatives to develop educational standards for health professionals in medicine development and update their glossary of ICH terms and definitions. These efforts are crucial in our global mission to elevate patient safety standards. I am proud to support CIOMS and their dedication to this vital cause. Together, we can make a significant impact on healthcare worldwide. #PatientSafety #RegulatoryAffairs #HealthcareInnovation #RealWorldEvidence #MedicalEducation #GlobalHealth #pharmout PharmOut

🔬 We’re thrilled to spotlight a fascinating paper co-authored by our own Alfred Whitehead, EVP, Applied Sciences, who collaborated with Paul Wardle and Erin Oliver. The paper is available in the December issue of RAPS Quarterly, published by the Regulatory Affairs Professionals Society (RAPS). 📜 The Article's Focus: the FDA’s proposed additional condition for nonprescription use (ACNU) rule—a transformative approach to patient-medication access. This rule could significantly alter the healthcare landscape, facilitating easier medication access by reducing barriers. 💡 The Significance: Patients, particularly those with chronic conditions, can be empowered to manage their health independently. The proposed ACNU pathway allows sponsors to use technology to ensure safe and effective use—without needing a physician. This rule can potentially alleviate burdens on healthcare systems, improve public health outcomes, and enhance patient autonomy. The paper describes the proposed rule and discusses how it may be applied. The article also explores how this pathway could increase access for those who might not seek traditional healthcare-provider visits, thus addressing a critical gap in current healthcare delivery. Want to know more? Klick Consulting has been assessing the ACNU for years and can help evaluate its impact on your business. 🔗 You can learn more about this FDA proposal through our partnership with RAPS at https://bit.ly/4bcY4x4 #KlickHealth #HealthcareInnovation #FDA #PatientCare #PharmaIndustry #RAPS

Are clinical networks key to UK market access success? Clinical networks often span multiple Integrated Care Boards (ICBS), and play a pivotal role in shaping national healthcare policy. By engaging with clinical networks, you will ensure that your strategy is informed by clinical expertise and aligned with national priorities. This makes your approach more effective, adaptive, and responsive to the real needs of the healthcare system. At Mtech Access, our NHS Associates include members of clinical networks, whose insights and perspectives can inform your strategy. Want to learn more about how we can support your market access strategy? Get in touch today at info@mtechaccess.co.uk #marketaccess #clinicalnetworks #healthcarestrategy #NHSinsights #ICBs #Pharma #Medtech

Are clinical networks key to UK market access success? Clinical networks often span multiple Integrated Care Boards (ICBS), and play a pivotal role in shaping national healthcare policy. By engaging with clinical networks, you will ensure that your strategy is informed by clinical expertise and aligned with national priorities. This makes your approach more effective, adaptive, and responsive to the real needs of the healthcare system. At Mtech Access, our NHS Associates include members of clinical networks, whose insights and perspectives can inform your strategy. Want to learn more about how we can support your market access strategy? Get in touch today at info@mtechaccess.co.uk #marketaccess #clinicalnetworks #healthcarestrategy #NHSinsights #ICBs #Pharma #Medtech

Gaining traction for #healthtech in the #NHS can be a challenge, but it is achievable. Effective approaches to health tech #marketing can contribute to success. If you would like to learn more, sign up to this webinar, where Highland Marketing's own Matthew D'Arcy will join Joop Tanis and specialists at Health Tech Enterprise to provide insights on what works well. Mark Venables, Susan Venables, Max Bardwell

How can your International Patient Department benefit from Temos Accreditation? Healthcare providers increasingly serve more diverse populations as well as domestic and international patients who expect personalized service. Hospital and clinic staff are challenged to respond to these rising demands while maintaining clinical excellence. The Temos team members understand and address these issues through its accreditation process. Temos avoids the “checklist” approach to accreditation. Instead, it offers an internationally accredited approach that is culturally sensitive, allowing for the customs and norms of specific locations to be observed. Originating in Germany, Temos is one of the world's leading healthcare accreditation bodies. Temos is the first and only accreditation organization offering healthcare accreditation combined with international patient management. Its patient-centered process includes an assessment of the patient journey for domestic and international patients while addressing the needs of the growing numbers of culturally diverse patients. Temos delivers value to patients and providers by meeting and exceeding expectations. Our accreditation programs are developed with the goal of refining medical protocols, aiming at protecting international patients against medical errors, and optimizing medical procedures for better efficiency and patient satisfaction. Are you ready to elevate your International Patient Department to new heights? Discover how Temos Accreditation can revolutionize your approach to healthcare delivery and patient satisfaction. Visit our website or reach out via email to learn more and embark on the journey toward excellence in patient care. 🌐 www.temos-worldwide.com ✉️ info@temos-international.com #temos #temosaccreditation #patientcare #healthcareexcellence #internationalpatients #medicalprotocols #patientjourney #healthcarequality #culturalcompetence #healthcareaccreditation

Is participation in clinical trials beneficial? Participating in clinical trials can offer a range of benefits for individuals, as well as for the broader medical and scientific communities. While there are numerous benefits, it is important for potential participants to be aware of the risks and to discuss these thoroughly with the clinical trial team and their healthcare provider before enrolling in a trial. Risks can include potential side effects, the possibility that the treatment may not be effective, and the time commitment involved.                                                                                                             #truelessons #onlinecourses #clinicalresearch #clinicaltrials #careersinclinicalresearch #onlinetraining Follow us on Social Media: https://lnkd.in/ggiWw7_a 🌐 Website: truelessons.io 📧Email: info@truelessons.io 📞 Call: +91 9620000023

Is participation in clinical trials beneficial? Participating in clinical trials can offer a range of benefits for individuals, as well as for the broader medical and scientific communities. While there are numerous benefits, it is important for potential participants to be aware of the risks and to discuss these thoroughly with the clinical trial team and their healthcare provider before enrolling in a trial. Risks can include potential side effects, the possibility that the treatment may not be effective, and the time commitment involved.     #truelessons #onlinecourses #clinicalresearch #clinicaltrials #careersinclinicalresearch #onlinetraining Follow us on Social Media: https://lnkd.in/gkyccWwZ  🌐 Website: truelessons.io  📧Email: info@truelessons.io  📞 Call: +91 9620000023

Have you ever wondered why Clinical Decision Support Systems (CDSS) are not a hot topic in healthcare conversations? It may be because their integration into our daily lives isn't as prominent as we would expect. CDSS are sophisticated tools designed to support healthcare professionals in making informed decisions, aligning closely with medical guidelines for improved patient outcomes.   Yet, the path to their widespread adoption is not without challenges. To me it feels like that regulatory barriers and the limited reimbursement options often relegate these innovative systems to being a DIY project within academic and hospital settings, rather than a mainstream solution embraced by the healthcare industry.   As I prepare to present my insights on CDSS at the upcoming PDA - Parenteral Drug Association conference on "Medical Devices and Connected Health" conference, I'm curious to hear your perspectives. What are your thoughts on CDSS, and how do you see them shaping the future of healthcare? So, see you in Antwerp, Belgium from 04-05 June 2024. #HealthTech #CDSS #InnovationInHealthcare #ClinicalDecisionSupport #DigitalHealth